ASICs as therapeutic targets for migraine

Neuropharmacology. 2015 Jul:94:64-71. doi: 10.1016/j.neuropharm.2014.12.015. Epub 2015 Jan 9.

Abstract

Migraine is the most common neurological disorder and one of the most common chronic pain conditions. Despite its prevalence, the pathophysiology leading to migraine is poorly understood and the identification of new therapeutic targets has been slow. Several processes are currently thought to contribute to migraine including altered activity in the hypothalamus, cortical-spreading depression (CSD), and afferent sensory input from the cranial meninges. Decreased extracellular pH and subsequent activation of acid-sensing ion channels (ASICs) may contribute to each of these processes and may thus play a role in migraine pathophysiology. Although few studies have directly examined a role of ASICs in migraine, studies directly examining a connection have generated promising results including efficacy of ASIC blockers in both preclinical migraine models and in human migraine patients. The purpose of this review is to discuss the pathophysiology thought to contribute to migraine and findings that implicate decreased pH and/or ASICs in these events, as well as propose issues to be resolved in future studies of ASICs and migraine. This article is part of the Special Issue entitled 'Acid-Sensing Ion Channels in the Nervous System'.

Keywords: ASIC; Cortical spreading depression; Dura; Headache; Meninges; Migraine.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Acid Sensing Ion Channel Blockers / pharmacology
  • Acid Sensing Ion Channel Blockers / therapeutic use*
  • Acid Sensing Ion Channels / metabolism*
  • Animals
  • Cortical Spreading Depression / drug effects
  • Cortical Spreading Depression / physiology
  • Humans
  • Migraine Disorders / drug therapy*
  • Migraine Disorders / metabolism*

Substances

  • Acid Sensing Ion Channel Blockers
  • Acid Sensing Ion Channels